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Melanosomes are specialized subcellular organelles 
in which melanin is synthesized and deposited. Elec-
tron microscopic, cytochemical, genetic, and biochem-
ical evidence all support the contention that melano-
somes are specialized lysosomes. The relationship of 
melanosomes and lysosomes provides a framework in 
which to understand the pathogenesis of disorders such 
as the Chediak-Higashi syndrome, allows the testing 
of hypotheses for the trafficking of proteins to mela-
M elanin pigments are tyrosine-based biopolymers synthesized and deposited within highly special-ized subcellular organelles termed melano-somes. This review addresses the ontogeny of melanosomes. The evidence in support of a 
common biogene tic pathway shared by melanosomes and the 
lysosomal lineage of organelles is reviewed. Melanosomes appear to 
represent highly specialized lysosomes. 
The lysosome-like nature of melanosomes allows a large body of 
knowledge accumulated from the study of lysosomes to be applied 
to pigment cell research. The biogenesis of lysosomes and the 
subcellular signals goveming the trafficking of proteins to lyso-
somes are in large part well understood, and may hold true for 
melanosomes as well. The relationship of melanosomes to lyso-
somes provides a framework by which the pathogenesis of multi-
system disorders that affect both organelles, such as the Chediak-
Higash.i and H ermansky-Pudlak syndromes, can be addressed . T he 
acidic nature oflysosome-like organ elles predicts that melanization 
normally takes place under acidic conditions, and that pharmaco-
logic manipulation of this acidification may allow us to modulate 
the quantity and quality of melanin synthesized. Finally, the 
lysosome-like nature of melanosomes may of!:er clues to the 
processing and presentation of melanosomal antigens by melanoma 
cells. 
THE BIOGENESIS OF MELANOSOMES 
More than 40 years ago [1] it was recognized that tyrosinase, the 
key melanogenic enzyme, existed in a particulate form. Subse-
quently, the subcellula.r organelle that fun ctions as the site of 
melanin deposition was identified by Seiji and co-workers [2] and 
termed the melanosome. 
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nosomes, and has important implications for the 
chemistry of melanization and the potential phanna-
cologic manipulation of that process. In addition, the 
lysosome-like nature of melanosomes may provide 
insight into the processing and presentation of mela-
nosomal antigens by melanoma cells. Keywords: albi-
nismlretitral pigment epitlreliumltyrosinase. ] Invest DeJ'ttra-
tol 105:3-7, 1995 
Beginning in the 19 50s, the e lectron microscope was used to 
generate much of our knowledge about the biogenesis of the 
melanosome . There are four stages in the maturation of the 
melanosome: stage I, the " premelanosome," a spherical organelle 
with ill-defin ed matrix filaments; stage II , in which th e typical 
elliptical shape of the melanosome is .filled with a well-defined 
filamentous or laminar matrix; stage Ill, with deposition of electron 
opaque m elanin on tlus matrix; and stage IV, with complete 
opacification of melanosomal con tents by the m elanin deposited 
therein [3] . While under natural conditions melanin deposition is 
limited to stage III-IV melanosom es; cytochemical staining for the 
DOPA oxidase activity of tyrosinase reveals the presence of the 
enzym e in the Trans-Golgi network (TGN), i11 a population of 
coated vesicles, as well as stage I-II m elanosomes [4-6]. T he most 
corrunonly accepted explanation for tlus observation involves a 
bipartite pathway for melanosomal biogenesis. First, "premelano-
somes" containing incompletely organized matri.x buds from tl1e 
TGN, and the matrix subsequently condenses into its readily 
recognizable form as a stage II melanosome. Concurrently or 
subsequently, coated vesicles that contain tyrosinase arise fro m the 
TGN. The fusion of these vesicles with the stage II melanosomes is 
beli eved to initiate the process ofmelanogenesis [3,5]. Purification 
of subsets of coated vesicles from actively melanizing 1uelanoma 
cells reveals that they have the expected high concentration of 
tyrosinase and m ehnun intem1ediates w itlun tl1em [7 ,8]. 
MELANOSOMAL ACID PHOSPHATASE 
By the late 1 960s cytochemical tecluuques allowed pigment cell 
researchers to investigate the distribution of other enzymes and 
compare them with tyrosinase. Acid phosphatase activi ty is found in 
several acidic organelles, including not only 1ysosom es, but also 
portions of the Golgi apparatus and various specialized secretory 
granules. Miyamoto and Fitzpatrick [91 had shown the presence of 
acid phophatase within tl1e chick retinal pigment epithelium. 
Cytochemical staining for tl1e activity of acid phosphatase revealed 
its presence witllin melanosomes in bo tl1 mammalian and avian 
melanocytes [10-12]. Furthermore, th e identical distribution of 
tyrosinase and acid phosphatase within the GERL (Golgi-endoplas-
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mic reticulum-lysosome) zone of che cell Jed Novikoff and co-
workers [6] to conclude that melanosomes and lysosomes might 
share a common biogenetic pathway. 
GENETIC EVIDENCE FOR A MELANOLYSOSOMAL 
RELATIONSHIP 
Some of the earliest and most compelling evidence in support of a 
shared biogenetic relationship between melanosomes and lyso-
somes was provided by the study of genetic diseases affecting 
pigmentation in humans and mice. Chediak-Higashi syndrome 
(CHS) is an autosomal recess ive disorder in humans characterized 
by oculocutaneous albinism and immunodeficiency [13) . Suscepti-
bility co a lymphoma-like phase, a bleeding diathesis, and neurop-
athy are all well described associated phenomena. The microscopic 
haU.mark of CHS is the presence of giant granules in m any cell and 
tissue types, including neutroph.ils, natural killer cells , melanocytes, 
fibroblasts, liver cells, etc [14,15). Studies at the light and electron 
microscopic levels suggested chat these giant granules arise by the 
aberrant fusion of these " lysosomally derived" organelles with one 
another. By contrast, an additional organelle, the platelet-dense 
granule, is either deficient or markedly reduced in those affected by 
CHS (16) . 
A second "melanolysosomal" disorder in humans is the Hennan-
sky-Pudlak syndrome [17]. In addition to the presence of oculocu-
taneous albinism, persons affected by this autosomal recessive 
disorder may suffer from a severe bleeding diathesis, interstitial 
pubnonary disease, and a granulomatous colitis. ln addition to the 
absence of platelet-dense granules on electron microscopic exam-
ination [18), other typical findings include the accumulatiotJ. of a 
ceroid-lipofuscin-like substance in the lysosomes of macrophages 
in the lung and the gut [1 9]. ll1creased urinary dolichol excretion 
also supports a lysosomal involvement [20]. 
A third autosomal recessive disorder associated with both lyso-
somal and pigmentary abnormalities is in f.1 ntiJe sialic acid storage 
disease. Affected infants succumb to a progressive storage di sorder 
typjfied by severe mental retardation and growth retardation. 
Hepatosplenomegaly and coarse facies are typ icaL Extreme dilution 
of the pigmentation of the skin as well as the associated sparse hair 
is well described [21,22]. 
In laboratory mice, numerous independent autosomal recessive 
mutations at an equ ivalent number of loci disrupt "melanolysoso-
mal" functions [23,24]. In addition to a dilution of coat coloc, each 
of these mutations also inhibits the usually brisk secretion of certain 
lysosomal hydrolases from renal cells into the urine. In addition, 
and reminiscent of the human disorders discussed above, many of 
these mutations also result in a bleeding diathesis associated with 
platelet dysfunction [25]. Detailed analysis of homozygous beige 
mice demonstrate that they are an excellent model for Chediak-
Higashi syndrome, with giant granules present in many tissues 
exam ined [26,27]. 
By 1979, the genetic data combined with the previously m en-
tioned data regarding acid phosphatase empowered Novak and 
Swank to state explicitly that "melanosomes and lysosomes share 
several structural and biosynthetic properties" [23]. 
TI-rE INTRAMELANOSOMAL pH IS ACIDIC 
A hallmark of endosomes, lysosomes, and related organelles is the 
maintenance of an acidic intraorganellar pH [28). Two appr()acbes 
have confi rmed the presence of the predicted low intramela.noso-
mal pH. Moellmann and co-workers employed immunocytocbem-
ica.l methods to show that the imi·amelanosomal pH is acidic [29]. 
Ramaiah and colleagues isolated melanosomes ·from B16 melanoma 
cells and assessed the incraorganellar pH with fluorescent probes. 
They estimated the intramelanosomal pH to be as low as 3-5 [30] . 
To date, the presence within m elanosomes of the multisubunit 
vacuolar ATPase responsible for lysosomal acidification has aot yet 
been proved formally, although a proton translocating ATPase 
activity with a pharmacologic profile similar to that of the vacuolar 
enzyme was demonstrated in melanosomes [30). 
Moellmann and colleagues [29] discussed some of the irnplica-
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
tions of an acidic intramelanosomal environment. Devi el a/ [31] 
had shown previously that pretreatment of murine tyrosinase at an 
acid ic pH ca uses tl1e enzyme to lose the lag period that it normally 
demonstrates with tyrosine as a substrate in the absence of added 
DOPA as cofactor. Subsequently, it became evident that this acidic 
pH might have additional implications for the chemistry of mela-
nization. For example, melanins rich in dillydrmryindole-2-carbox-
ylic acid are soluble at n eutral pH but become progressively 
insoluble as the pH is lowered to 5 [32]. 
If melanization indeed takes place in a lysosome-like acidic 
organelle, then one might hypothesize that che modulation of 
i.ntramelanosomal pH affords a means of modulating melanogenesis 
pharmacologically. Drugs that block the putative melanosomal 
proton-transporting ATPase, for example, might alter tl1e quantity 
and/or quality of melanin deposited therein. 
MELANOSOMES ARE SPECIALIZED L YSOSOMES 
Although acid phosphatase and proton-translocating ATPase activ-
ities are present within melanosomes, the first protein formally 
proved to be shared by lysosomes and melanosomes was the 
lysosomal membrane glycoprotein Lamp-1 [33 ,34]. In addition, 
Lamp-1 was identified in vesicles implicated in the trafficking of the 
tyrosinase-related protein family to melanosomes [34,35]. We have 
subsequently found that the related protein Lamp-2 is similarly 
distributed. 
If melanosomes are indeed specialized lysosomes, then they 
might be predicted to contain a wide array oflysosomal hydrolases. 
Smit and co-workers [36) studied extracts of human melanocytes 
subjected to density gradient fractionation and found that a portion 
of tyrosinase co-migrated with the lysosomal hydrolase a-glucosi-
dase but was clearly separable from peroxisomal markers. By 
combining cell fractionation techniques with the use of genetic 
controls, we have recently demonstrated that melanosomes are the 
major repository in m elanocytes of such lysosomal hydrolases as 
J3-glucuronidase, J3-galactosidase, J3-hexosaminidase, and cathep-
sins B and L [3 7]. 
Typical of lysosomes is their accessibility to molecules internal-
ized via both endocytosis and phagocytosis [38]. Melanosom es 
seem to behave in a similar fashion. Melanocyte-stimulating hor-
mone internalized 11ia its receptor has been shown to make its way 
to melanosomes [29]. Even more convincing, however, is the 
observation by two independent groups that phagosomes contain-
ing latex particles internalized by melanocytes or m elanoma cells i11 
culture can fuse with me1anosomes [39,40]. Finally, e lectron mi-
croscopic examination of cultured retinal pigment epithelial cells 
demonstrated the presence of tyrosinase and melanosomaJ matrix 
within phagosomes [41]. 
By 1993, numerous authors could look back upon this growing 
body of data and conclude that m elanosomes were indeed special-
ized lysosomes [34,40,41]. 
TRAFF!CKJNG TO MELANOSOMES 
The delineation of the relationship between melanosomes and the 
endolysosomal lineage of organelles has implications not only for 
bettering our understanding of how the melanosome evolved, but 
also for determining the signals responsible for the trafficking of 
proteins to melanosomes. Elucidation of the signals governing 
protein trafficking are important not merely to the molecular and 
cell biologist, but to the clinician as well; numerous examples now 
exist of diseases caused by abnormal protein trafficking [42] . 
The motifs directing membrane proteins to endolysosomal or-
ganelles are well studied. A recent review summarizes the role in 
subcellular trafficking of specific tyrosine and basic amino acid-
based motifs found in uumerous endolysosomal proteins [43] . [n 
each case, a stretch of four to five basic amino acids in the protein's 
cytoplasmic tail is followed by a tyrosine residue just proximal to 
the protein's carboJI.]' terminus. Like many of these proteins , the 
members of the tyrosinase-related protei11 family are type 1 me m-
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brane proteins, w ith lo ng in traluminal amino-termin al dotn<tins and 
short cytoplasmic tails separated by a single transmembrane do-
m ain . Pote nti al tyrosine- and bas ic amino acid-based trafficking 
motifs are presen t withi.n the cytoplasmic tail s of the T RP family. 
If these motifs are removed by molecular m anipulatio n , endoly-
sosonl.al pro teins traffic to the plasm a membrane rather than to 
e ndolysosomes, following the "default" pathway for other cellular 
m embran e prote ins [44,45]. VUayasaradhi and co-workers are 
employin g m olecular techniques to investiga te this problem and 
preliminary reports suggest that, as for endolysosom al proteins, the 
cytoplasmic tail is critical for correct subceUular trafficking of the 
TRP family .* 
We have recently found that the severe oc ulocutaneous hypop-
igmentation caused by the pla ti1111111 mutation at the murine albi11 o 
locus is due to misrouting of an enzymatically active mutant 
tyrosinase with a trunca ted cytoplasmic tail to the m elanocyte 
p lasma m embran e rath er than to m elanosom es:r If melanosomes 
are indeed specialized lysosomes, then it might be predicted that 
m embers of the TRP family expressed in nonmelanocytic cells 
would traffic to endolysosomes. Numerous studies demonstrate th e 
accuracy of this prediction . When tyrosinase and TRP-1 are 
expressed in fibrob lasts, they loca lize to organell es that stain 
positively for the lysosomal hydro.lase ,B-glucuronidase as well as for 
Lamp-l (46,47]. 
Altho ugh the cytoplasmic ta il of the Pmel17 I si/ tJt:r locus protein 
bears som e homology to those of the TRP fa mily [ 48], the mature 
Pmel 17 I si/IJer protein be haves as an in tramelanosomal matrix 
protein rather than as an integral m embran e protein [ 49]. T he 
predicted tran sm embran e domain may be lost following proteolysis 
within the mclanosome [50,51] . Preceden t for the trafficking of a 
m embran e protein to lysosom es directed by signals in its cytoplas-
mic tail followed by its subsequent cleavage into a soluble protein 
is supported by the study of acid phosphatase . T his enzym e is 
carried to the plasma m embran e via the "default" pathway and is 
then i11terna Li zed via endocytosis [ 45]. Upon arrival within the 
lysosom e, the protein is cleaved to solubl e form [45]. 
How do the lysosomal hydrolases detected w ithin melanosomes 
traffic to this organ elle? The classic pathway by w hich these 
hydrolases traffic to lysosom es in volves the modification of their 
tern1.inal m annose residues to a mannose 6-phosphate (52]. T hese 
mannose 6-phospho rylated enzym es bind to the m embrane-bo und 
mannose 6-phosphate receptor in the Golgi apparatu s. T hey are 
carried to late endosomes and, in the presence of the low pH in that 
o rgane!Je, are re leased from the receptor into the endosome's 
lumen (53,54]. Subsequently, this organel.le m atures into a lyso-
som e . 
D eficien cies of indi vidua.l hydrolases arc well desc•·ibed in hu-
m ans, and are not gene rally associated with hypopigm entation. In 
con trast, in T-cell disease, a wide range ofl ysosomal hydro lases are 
not phosphorylated on mannose residues due to the absence of a 
specific phosphotransferase. A severe lysosomal storage disorder 
eventuates becau se the unmodified hydrolases are secreted o ut of 
the ce Ll rather than be ing transported to endolysosom es (55]. 
Nonetheless, ce l.l s such as lymphocytes are barely affected; recent 
~viden ce suggests that, in som e tissues, a m annose 6-phospbate-
mdependen t pathway is operative [56]. Even l-cell disease is 
associ:lted with, <lt m ost,_ a mild hypopigmentation of scalp hairs 
over time [55]. Two poss1ble explanatio ns (not mutually exclusive) 
can be proffered: 1) the presence of lysosomal hydrolases within 
m elanosom es is not critical to successfu l melanogenesis or 2) in 
~elanocytes , lysosomal hy~rolases traft.ic to mel anosomes largely 
v1a mannose- 6 phosphate-mdependent m eans. Fu rther studies are 
needed to evaluate these two possibilities. 
• Vijayasaradhi S, Xu Y: Identifica tion ofsibrna.ls for sorting and targeting 
of melanosomal membrane proteins (abstr). Pi,g 111 e111 Cell Res 6:276, 1993 . 
_t Beem1an F, O rlow SJ , Boissy R.E, Schmidt A, Boissy YL, Lamoreux L: 
M.1srouting of tyrosinase with a truncated cytoplasmic tail as a result of the 
munne plati1111111 (c1') mutation (submitted for publication) . 
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WHY SHOULD MELANOSOMES BE "LYSOSOME-LIKE"? 
T he lysosome, being low pH, high u1 hydrol ase concentration , and 
men~bran e rich in heavily glycosylated proteins, is designed to can-y 
o ut Its degradative function s in a se tting we ll segregated fro m tl1e 
cell 's cytoplasm. Given what we know of the potentially dam aging 
effects on cells of the process of m elanin deposition, including the 
generation of highly reactive oxidative in termediates, it is perhaps 
not surprising that th e organell e that evolved to contain this process 
is a specialized lysosom e. In support of this hypoth esis is . recent 
evidence w e o btained by exarnining pig m ented versus amelanotic 
m elanocytes in culntre. W e have shoWl.l that the levels of five 
typical " lysosomal" hydrolases present w ithin melanosomes are 
grea tly elevated u1 m elanocytes cultured from black mice when 
compar ed with those from albino mice [37] . Even more surprising 
are t ~1e o bservations that the transfection of the gen es encoding 
tyrosm ase and TRP-1 into nonmclanocytic cells such as fibrobla sts 
(which can be accompanied by m elru1in deposition within endo-
lysosomes) is al so associated with elevated levels of selected 
lysosomal m embran e proteins [57] and lysosom al hydrolases.:j: 
Take•_, togeth er , these results suggest that the elevation oflysosomal 
prote_m l ~vel s IS a gen eral (protective?) response to th e presence of 
ongo mg mtracellular m e lanin synthesis. 
IMPLICATIONS FOR MELANOMA BIOLOGY 
Cancer biologists_ have long searched for tumo r-associated an tigens, 
ell:-p ressed exclusively by transformed cells and tl1erefore potential 
targ~ts fo: im1~1tme-medi ated tumor destruction. One approach to 
the JdentJficatJon of such molecules has entailed the isolation of 
tumor-infiltrating lymphocytes (TlLs) . R ecen t studies have eluci-
dated_ a numbe r of antigens speci.fica.l ly recognized b y melanoma 
assoCiated T !Ls [58 - 60]. Altl10ugh a few of these an tigens repre-
sent_ h eretofore undescribed m o lecules, others are tantalizingly 
f<~•mhar . Se~e~~.l of the recently described T IL targets are major 
h1stocompatlb1hty complex-associated peptides derived from the 
processing of the m elan osomal protein s tyTosinase and gp100 
[59,60] . 
Tyrosi11ase is a m e lanosoma l m embrane protein weLl known to 
any stu~ent of _pigment cell biology . T he gp100 antigen , or its 
alte m atlvely sphced fonn , pmel17 I silver locus prote in referred to 
above, are, in fact, the antigens recognized by three differen t 
n~onocl?nal antibodies employed widely for tl1e histopathologic 
dwgnoSJS c:>f melanoma: HMBSO, HMB45, and NJG i beteb (61 ]. 
R ecent ev1dence suggests that gp100 m ay be processed so that its 
final location is in the m elanosome's in terior, as part of the 
fi lam_e nto us _melanosom al matrL-x; indeed, it is homologous to a 
m atrix protem found in avian retinal pigmented epithelium [62] . 
How do m elanosom al proteins becom e proteolyzed peptides 
bound to major histocompatibility complex molecules on the 
m elru10m a cell surface? One possible explanation is based on the 
fact that antigen processing i11 m acrophages takes place w ithin 
the endolyso_somal compartment. It is there that proteins are 
p~oteolyzed tnto peptides tha t may then gain access to major 
h1stocompatibility complex molecules and bu1d to them prior to 
their trafficking to the cell surface. We h ave shown that proteases 
such as cathepsins Band L are present within the m elan osom e (37], 
and thus m elru1osomal proteins such as tyrosinase ru1d gpl 00 migh t 
en co un ter proteolytic processin g enzym es the re. 
Why are these melanosom a] proteins not processed and pre-
sented in the context of m aj or histocompatibility complex m ole-
cules o n the surface of normalmelanocytes? T he answer m ay lie in 
the subcellular differences between m elanoma cells ru1.d normal 
m clan ocytes. It has long been recognized tl1at m elanoma cells 
produ ce m elanosom es rangu1g fi·om the overtly normal to the 
gross ly deform ed (63- 65]. It is likely that the proteolytic processing 
of m elanosomaJ proteins is suppressed in norm al m elanocytes; this 
:j: llorovans!..)' J, Mommaas M, Smi t N. Eggcndaal D, Winder AJ , 
Vermeer Bj , Pavel S: Melanogenesis in transfectcd fi broblasts induces 
lysosomal activation (abstr). Mcln iiOII tn .Res 4(suppl 2):16, 1994. 
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regulatory mechanism may be aberrant in melanoma cells. ln 
support of this hypothesis is the observation that acid protease levels 
may be highly elevated in transformed cells including melanocytes 
[66-68]. For example, we have found that although transfom1ation 
of murine melanocytes with the v-rasHA oncogene downregulates 
expression of the TRP family as well as the levels of a number of 
lysosomal hydro lases [3 7], levels of cathepsins B and L are markedly 
elevated.§ The qu estion of melanosoma1 antigen processing re-
mains a fruitful area for future melanoma research. 
SUMMARY 
Genetic, cellular, and biochemical data all support a close associa-
tion between melanosomes and the endolys osomal lineage of 
organelles . Far from just being a cell biologic curiosity, tlus 
relationship has important implications for the pathogenesis of 
gene tic disorders as well as for the processing and presentation of 
melanoma-associated antigens by melanoma cells. 
This work was supported i11 pm·t by NIH gra11ts AR 41880 a11d EY 10223, a111l a 
Career Scielllist AwardJi-otll the Irma T. Hirschi Trust. 1 tha11k). A11i11sjor the 
preparntio11 of the tllalluscript. 
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